As of 2024-07-27, the EV/EBITDA ratio of BioLife Solutions Inc (BLFS) is -32.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BLFS's latest enterprise value is 1,103.57 mil USD. BLFS's TTM EBITDA according to its financial statements is -34.49 mil USD. Dividing these 2 quantities gives us the above BLFS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 13.4x | 13.2x |
| Forward P/E multiples | 7.4x - 11.4x | 9.6x |
| Fair Price | (8.55) - (8.45) | (8.43) |
| Upside | -135.6% - -135.1% | -135.1% |
| Date | EV/EBITDA |
| 2024-07-26 | -32.00 |
| 2024-07-25 | -30.65 |
| 2024-07-24 | -29.74 |
| 2024-07-23 | -30.29 |
| 2024-07-22 | -28.85 |
| 2024-07-19 | -27.97 |
| 2024-07-18 | -28.54 |
| 2024-07-17 | -29.96 |
| 2024-07-16 | -30.30 |
| 2024-07-15 | -27.67 |
| 2024-07-12 | -27.57 |
| 2024-07-11 | -27.90 |
| 2024-07-10 | -25.68 |
| 2024-07-09 | -25.52 |
| 2024-07-08 | -27.20 |
| 2024-07-05 | -26.60 |
| 2024-07-03 | -26.64 |
| 2024-07-02 | -26.91 |
| 2024-07-01 | -27.66 |
| 2024-06-28 | -28.51 |
| 2024-06-27 | -27.27 |
| 2024-06-26 | -28.59 |
| 2024-06-25 | -28.42 |
| 2024-06-24 | -28.62 |
| 2024-06-21 | -27.94 |
| 2024-06-20 | -27.71 |
| 2024-06-18 | -26.55 |
| 2024-06-17 | -26.94 |
| 2024-06-14 | -26.87 |
| 2024-06-13 | -27.32 |
| 2024-06-12 | -28.97 |
| 2024-06-11 | -28.49 |
| 2024-06-10 | -28.63 |
| 2024-06-07 | -27.00 |
| 2024-06-06 | -27.62 |
| 2024-06-05 | -28.66 |
| 2024-06-04 | -27.82 |
| 2024-06-03 | -28.29 |
| 2024-05-31 | -28.58 |
| 2024-05-30 | -28.94 |
| 2024-05-29 | -28.73 |
| 2024-05-28 | -29.45 |
| 2024-05-24 | -28.90 |
| 2024-05-23 | -28.06 |
| 2024-05-22 | -29.11 |
| 2024-05-21 | -28.85 |
| 2024-05-20 | -29.05 |
| 2024-05-17 | -29.22 |
| 2024-05-16 | -29.24 |
| 2024-05-15 | -30.60 |